| |
Number of patients (percentage), excluding missing data
|
|---|
|
CCLG
|
GPOH
|
|---|
|
N
|
None
|
RT alone
|
Surgery alone
|
RT and surgery
|
N
|
None
|
RT alone
|
Surgery alone
|
RT and surgery
|
|---|
|
Disease
|
|
Localised
|
150
|
9 (6)
|
53 (35)
|
59 (39)
|
29 (19)
|
315
|
3 (1)
|
55 (17)
|
63 (20)
|
194 (62)
|
|
Metastatic
|
56
|
9 (16)
|
27 (48)
|
11 (20)
|
9 (16)
|
101
|
4 (4)
|
30 (30)
|
8 (8)
|
59 (58)
|
|
Localised extremity disease
|
91
|
5 (5)
|
18 (20)
|
46 (50)
|
22 (24)
|
155
|
1 (1)
|
8 (5)
|
44 (28)
|
102 (66)
|
|
Localised pelvic disease
|
31
|
0
|
24 (77)
|
6 (19)
|
1 (3)
|
79
|
1 (1)
|
27 (36)
|
7 (9)
|
39 (53)
|
|
Primary site
|
|
Central axis
|
84
|
9 (11)
|
52 (62)
|
14 (17)
|
9 (11)
|
226
|
4 (2)
|
73 (32)
|
22 (10)
|
127 (56)
|
|
Extremity
|
115
|
7 (6)
|
28 (24)
|
54 (47)
|
26 (23)
|
189
|
3 (2)
|
11 (6)
|
48 (25)
|
127 (67)
|
|
Volume (ml)
|
|
< 100
|
57
|
5 (9)
|
19 (33)
|
27 (47)
|
6 (10)
|
111
|
3 (3)
|
26 (23)
|
16 (14)
|
66 (59)
|
|
≥ 100
|
146
|
13 (9)
|
61 (42)
|
40 (27)
|
32 (22)
|
292
|
4 (1)
|
54 (18)
|
52 (18)
|
182 (62)
|
|
Age (years)
|
|
0–9
|
34
|
0
|
10 (29)
|
22 (65)
|
2 (6)
|
92
|
1 (1)
|
18 (20)
|
22 (24)
|
51 (55)
|
|
10–14
|
74
|
5 (7)
|
32 (43)
|
24 (32)
|
13 (18)
|
118
|
0
|
30 (25)
|
11 (9)
|
77 (65)
|
|
15–19
|
56
|
5 (9)
|
25 (45)
|
13 (23)
|
13 (23)
|
111
|
3 (3)
|
21 (19)
|
21 (19)
|
66 (59)
|
|
20–35
|
43
|
8 (19)
|
14 (33)
|
11 (26)
|
10 (23)
|
97
|
3 (3)
|
16 (16)
|
17 (18)
|
61 (63)
|
- Chi square tests were used to examine the association between each factor and choice of local therapy, excluding those who received no local treatment (‘None’ in the table)
- CCLG: disease (p = 0.04); primary site (p < 0.001); volume (p = 0.01); age (p = 0.01)
- GPOH: disease (p = 0.002); primary site (p < 0.001); volume (p = 0.44); age (p = 0.12)
- N total number of patients RT radiotherapy
